ES71
TEAS SECTION 71 RECEIVED
18/05/2026
Voltar para busca
Dado oficial do USPTO
KYOWA KIRIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
19/05/2026
Tipo de marca
Mista
Classes Nice
5, 40, 42, 44
Data de depósito
25/01/2019
Data de registro
19/05/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/05/2020
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
JP
Examinador
CHANG, ELIZABETH YI HSUAN
Unidade examinadora
O30
Localização atual
POST REGISTRATION
Descrição da marca
The mark consists of the stylized wording "KYOWA KIRIN" wherein the initial letter "K" is superimposed over two overlapping irregular ovals.
Titulares e representantes
Titulares
KIRIN HOLDINGS KABUSHIKI KAISHA (also trading as Kirin Holdings Company, Limited)
KIRIN KABUSHIKI KAISHA (also trading as KIRIN Company, Limited)
Representantes
Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of cancer or malignant tumorspainhematological disordersrenal diseaseendocrine diseasesimmunity disordersneurologicalpsychiatric and other central nervous system disorders; pharmaceutical preparations for supportive care in the treatment of cancer or malignant tumors; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes; cell culture mediums for medical and veterinary purposes; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; antiseptic absorbent cotton; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animals
Classe 40
Custom manufacture of pharmaceuticals; extractionproduction and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for others
Classe 42
Pharmaceutical research; research of chemicals; analysis of chemicals; testinginspection or research of pharmaceuticals; testinginspection or research of chemicals; testinginspection or research of cosmetics; testinginspection or research of foodstuff; providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development; rental of laboratory apparatus; rental of laboratory instruments
Classe 44
Providing medical information; medical examinations; preparation and dispensing of medication; dietary and nutritional guidance; veterinary services; rental of medical apparatus; rental of medical instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19/05/2025
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
29/10/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
28/10/2021
PLGL
ASSIGNED TO PARALEGAL
28/10/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
23/10/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/12/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
23/09/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
23/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
19/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
28/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/01/2020
ALIE
ASSIGNED TO LIE
29/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/11/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/10/2019
RFNT
REFUSAL PROCESSED BY IB
09/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/07/2019
RFRR
REFUSAL PROCESSED BY MPU
23/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/07/2019
CNRT
NON-FINAL ACTION WRITTEN
01/07/2019
DOCK
ASSIGNED TO EXAMINER
26/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KYOWA KIRIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.